Journal
MOVEMENT DISORDERS
Volume 29, Issue 9, Pages 1208-1212Publisher
WILEY-BLACKWELL
DOI: 10.1002/mds.25946
Keywords
Parkinson's disease; olfaction; psychophysics; L-DOPA; perception
Categories
Funding
- USAMRAA [W81XWH-09-1-0467]
Ask authors/readers for more resources
Background: Whether Parkinson's disease (PD) influences suprathreshold changes in perceived odor intensity is unknown. In patients with Alzheimer's disease, patients with schizophrenia, and the elderly, such perception is reportedly normal. If generally true, this could reflect a core element of the olfactory system insulated to some degree from age-and disease-related pathological conditions. Methods: Odor intensity ratings for pentyl acetate were obtained from 29 early-stage PD patients when on and off dopamine-related medications (DRMs) and from 29 matched controls. Results: The ratings were significantly attenuated at the higher odorant concentrations, with the degree of attenuation associated with overall olfactory dysfunction. Ratings were higher on the right than on the left side of the nose of both patients and controls. No associations with DRMs, Unified Parkinson's Disease Rating Scale (UPDRS) scores, or striatal dopamine transporter imaging were found. Conclusions: Parkinson's disease (PD) influences suprathreshold estimates of perceived odor intensity, negating the notion that such perception might be spared in this disease. No association with dopaminergic processes was apparent. (C) 2014 International Parkinson and Movement Disorder Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available